Not at all Kelton...I spoke to a highly credentialed “Infectious diseases” professor who is very high up in Australia’s research bodies...I know its not his field...but he knows my interest in B-Cell...he commented recently when I asked if he’d bought any IMU and he replied that it’s still not proven whether B-Cell actually works.
I believe this is why IMU is priced where it’s at...the scientific community don’t believe it...YET...
This is where the extreme upside is...in Axels article recently he was hinting at big cancer breakthroughs to come shortly...I’d take that seriously from someone like Axel.
Imugene is in the middle of an open proof of concept phase 2 trial in Her-Vaxx...the company knows what results they’re getting and reading an article like this from Axel gives me great confidence that my infectious diseases professor will soon be a shareholder
Ann: Imugene Receives Ethics Approval to Start PD1-VAXX Trial, page-52
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $424.8K | 8.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 8622849 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1925890 | 9 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |